Give a gift to Leukaemia Care and help us support leukaemia patients
We use cookies to provide a better service. Keep browsing if you're happy with this, or read our cookie policy.
Menu
08088 010 444
Search results for "benefits"
Blog
Adjusting to life after your diagnosis? Nick York, Leukaemia Care's Patient Advocacy Healthcare Liaison Officer and chronic lymphocytic leukaemia (CLL) patient shares how his love of gardening has transformed his mindset following his diagnosis.
In this blog, our Welfare Advisor shares her tips on how to save money on your energy bills, how to make your home as energy-efficient as possible, as well as share any grants available.
Nick York, Campaigns and Advocacy Officer and chronic lymphocytic leukemia (CLL) patient, shares his tips on staying healthy through the winter months.
News
Leukaemia Care and Leukaemia UK have launched a new Cost of Living with Leukaemia Fund in response to the cost of living crisis in the UK to help support leukaemia, MDS and MPN patients this winter.
Leukaemia Care successfully campaigns for the Scottish Medicines Consortium (SMC) to approve asciminib in Scotland for chronic myeloid leukaemia (CML) patients after 2 or more other tyrosine kinase inhibitors (TKIs).
Page
Get access to our free online learning modules curated especially for GP's and healthcare professionals - helping them to learn about the symptoms of leukaemia.
Leukaemia Care successfully campaigns for the National Institute for Health and Care Excellence (NICE) to approve asciminib on the NHS in England for chronic myeloid leukaemia (CML) patients after 2 or more tyrosine kinase inhibitors (TKIs).
Online Webinars
This webinar aims to explore what may be of help by sharing the experience, information, and advice of the panel of patients and clinical nurse specialists.
Where: At home
The aim of this webinar is to help inform you about how clinical trials are run and elements you should consider when making decisions.
In this blog we explain what we know about the preventative COVID-19 treatment, Evusheld, and answer some of the most common questions we have received from patients.